Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q43003659
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000317.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q43003659
|
024
|
|
|
‡a
0000-0003-2467-2090
‡2
orcid
|
024
|
|
|
‡a
6603753936
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q43003659
|
100
|
0 |
|
‡a
Mar García-Rocha
‡9
ast
‡9
sl
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
Mar García-Rocha
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Mar García-Rocha
‡c
wetenschapper
‡9
nl
|
400
|
0 |
|
‡a
Mar García-Rocha
‡c
investigadora
‡9
es
|
670
|
|
|
‡a
Author's A new level of regulation in gluconeogenesis: metabolic state modulates the intracellular localization of aldolase B and its interaction with liver fructose-1,6-bisphosphatase.
|
670
|
|
|
‡a
Author's Circadian- and UPR-dependent control of CPEB4 mediates a translational response to counteract hepatic steatosis under ER stress.
|
670
|
|
|
‡a
Author's Control of glycogen deposition.
|
670
|
|
|
‡a
Author's Control of liver glycogen synthase activity and intracellular distribution by phosphorylation.
|
670
|
|
|
‡a
Author's Deleterious effects of neuronal accumulation of glycogen in flies and mice
|
670
|
|
|
‡a
Author's Differential glucose metabolism in mice and humans affected by McArdle disease.
|
670
|
|
|
‡a
Author's FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth
|
670
|
|
|
‡a
Author's Genetic models rule out a major role of beta cell glycogen in the control of glucose homeostasis
|
670
|
|
|
‡a
Author's Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis.
|
670
|
|
|
‡a
Author's Glucose 6-phosphate produced by gluconeogenesis and by glucokinase is equally effective in activating hepatic glycogen synthase
|
670
|
|
|
‡a
Author's Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease
|
670
|
|
|
‡a
Author's Glycogen storage in the human retinal pigment epithelium: a comparative study of diabetic and non-diabetic donors
|
670
|
|
|
‡a
Author's Hepatic Overexpression of a Constitutively Active Form of Liver Glycogen Synthase Improves Glucose Homeostasis
|
670
|
|
|
‡a
Author's Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1
|
670
|
|
|
‡a
Author's Liver glycogen synthase but not the muscle isoform differentiates between glucose 6-phosphate produced by glucokinase or hexokinase.
|
670
|
|
|
‡a
Author's Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy.
|
670
|
|
|
‡a
Author's Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease
|
670
|
|
|
‡a
Author's Protein kinases involved in the phosphorylation of human tau protein in transfected COS-1 cells.
|
670
|
|
|
‡a
Author's Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149.
|
670
|
|
|
‡a
Author's Restoration of hepatic glycogen deposition reduces hyperglycaemia, hyperphagia and gluconeogenic enzymes in a streptozotocin-induced model of diabetes in rats
|
670
|
|
|
‡a
Author's Structural basis for the recruitment of glycogen synthase by glycogenin
|
670
|
|
|
‡a
Author's Subcellular localization of liver FBPase is modulated by metabolic conditions.
|
670
|
|
|
‡a
Author's The antitumoral compound Kahalalide F acts on cell lysosomes
|
670
|
|
|
‡a
Author's Tissue-type plasminogen activator (tPA) is the main plasminogen activator associated with isolated rat nerve growth cones
|
909
|
|
|
‡a
(scopus) 6603753936
‡9
1
|
909
|
|
|
‡a
(orcid) 0000000324672090
‡9
1
|
919
|
|
|
‡a
tissuetypeplasminogenactivatortpaisthemainplasminogenactivatorassociatedwithisolatedratnervegrowthcones
‡A
Tissue-type plasminogen activator (tPA) is the main plasminogen activator associated with isolated rat nerve growth cones
‡9
1
|
919
|
|
|
‡a
antitumoralcompoundkahalalidefactsoncelllysosomes
‡A
The antitumoral compound Kahalalide F acts on cell lysosomes
‡9
1
|
919
|
|
|
‡a
subcellularlocalizationofliverfbpaseismodulatedbymetabolicconditions
‡A
Subcellular localization of liver FBPase is modulated by metabolic conditions.
‡9
1
|
919
|
|
|
‡a
structuralbasisfortherecruitmentofglycogensynthasebyglycogenin
‡A
Structural basis for the recruitment of glycogen synthase by glycogenin
‡9
1
|
919
|
|
|
‡a
restorationofhepaticglycogendepositionreduceshyperglycaemiahyperphagiaandgluconeogenicenzymesinastreptozotocininducedmodelofdiabetesinrats
‡A
Restoration of hepatic glycogen deposition reduces hyperglycaemia, hyperphagia and gluconeogenic enzymes in a streptozotocin-induced model of diabetes in rats
‡9
1
|
919
|
|
|
‡a
regulationofglycogenmetabolisminculturedhumanmusclesbytheglycogenphosphorylaseinhibitorcp91149
‡A
Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149.
‡9
1
|
919
|
|
|
‡a
proteinkinasesinvolvedinthephosphorylationofhumantauproteinintransfectedcos1cells
‡A
Protein kinases involved in the phosphorylation of human tau protein in transfected COS-1 cells.
‡9
1
|
919
|
|
|
‡a
neurodegenerationandfunctionalimpairmentsassociatedwithglycogensynthaseaccumulationinamousemodeloflaforadisease
‡A
Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease
‡9
1
|
919
|
|
|
‡a
mechanismsuppressingglycogensynthesisinneuronsanditsdemiseinprogressivemyoclonusepilepsy
‡A
Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy.
‡9
1
|
919
|
|
|
‡a
liverglycogensynthasebutnotthemuscleisoformdifferentiatesbetweenglucose6phosphateproducedbyglucokinaseorhexokinase
‡A
Liver glycogen synthase but not the muscle isoform differentiates between glucose 6-phosphate produced by glucokinase or hexokinase.
‡9
1
|
919
|
|
|
‡a
hypoxiapromotesglycogenaccumulationthroughhypoxiainduciblefactorhifmediatedinductionofglycogensynthase1
‡A
Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1
‡9
1
|
919
|
|
|
‡a
hepaticoverexpressionofaconstitutivelyactiveformofliverglycogensynthaseimprovesglucosehomeostasis
‡A
Hepatic Overexpression of a Constitutively Active Form of Liver Glycogen Synthase Improves Glucose Homeostasis
‡9
1
|
919
|
|
|
‡a
glycogenstorageinthehumanretinalpigmentepitheliumacomparativestudyofdiabeticandnondiabeticdonors
‡A
Glycogen storage in the human retinal pigment epithelium: a comparative study of diabetic and non-diabetic donors
‡9
1
|
919
|
|
|
‡a
glycogenaccumulationunderliesneurodegenerationandautophagyimpairmentinlaforadisease
‡A
Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease
‡9
1
|
919
|
|
|
‡a
glucose6phosphateproducedbygluconeogenesisandbyglucokinaseisequallyeffectiveinactivatinghepaticglycogensynthase
‡A
Glucose 6-phosphate produced by gluconeogenesis and by glucokinase is equally effective in activating hepatic glycogen synthase
‡9
1
|
919
|
|
|
‡a
glucose6phosphatemediatedactivationofliverglycogensynthaseplaysakeyroleinhepaticglycogensynthesis
‡A
Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis.
‡9
1
|
919
|
|
|
‡a
geneticmodelsruleoutamajorroleofbetacellglycogeninthecontrolofglucosehomeostasis
‡A
Genetic models rule out a major role of beta cell glycogen in the control of glucose homeostasis
‡9
1
|
919
|
|
|
‡a
foxaandlipgendotheliallipasecontroltheuptakeofextracellularlipidsforbreastcancergrowth
‡A
FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth
‡9
1
|
919
|
|
|
‡a
differentialglucosemetabolisminmiceandhumansaffectedbymcardledisease
‡A
Differential glucose metabolism in mice and humans affected by McArdle disease.
‡9
1
|
919
|
|
|
‡a
deleteriouseffectsofneuronalaccumulationofglycogeninfliesandmice
‡A
Deleterious effects of neuronal accumulation of glycogen in flies and mice
‡9
1
|
919
|
|
|
‡a
controlofliverglycogensynthaseactivityandintracellulardistributionbyphosphorylation
‡A
Control of liver glycogen synthase activity and intracellular distribution by phosphorylation.
‡9
1
|
919
|
|
|
‡a
controlofglycogendeposition
‡A
Control of glycogen deposition.
‡9
1
|
919
|
|
|
‡a
circadiananduprdependentcontrolofcpeb4mediatesatranslationalresponsetocounteracthepaticsteatosisundererstress
‡A
Circadian- and UPR-dependent control of CPEB4 mediates a translational response to counteract hepatic steatosis under ER stress.
‡9
1
|
919
|
|
|
‡a
newlevelofregulationingluconeogenesismetabolicstatemodulatestheintracellularlocalizationofaldolasebanditsinteractionwithliverfructose16bisphosphatase
‡A
A new level of regulation in gluconeogenesis: metabolic state modulates the intracellular localization of aldolase B and its interaction with liver fructose-1,6-bisphosphatase.
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
ISNI|0000000067811554
|
996
|
|
|
‡2
ISNI|0000000070609007
|
996
|
|
|
‡2
ISNI|0000000070520053
|
996
|
|
|
‡2
CAOONL|ncf11688094
|
996
|
|
|
‡2
PTBNP|216130
|
996
|
|
|
‡2
ISNI|0000000067804952
|
996
|
|
|
‡2
PTBNP|136235
|
996
|
|
|
‡2
PTBNP|177879
|
996
|
|
|
‡2
PTBNP|94956
|
996
|
|
|
‡2
PTBNP|108877
|
996
|
|
|
‡2
ISNI|0000000069007682
|
996
|
|
|
‡2
LC|n 89149697
|
996
|
|
|
‡2
ISNI|0000000070615968
|
996
|
|
|
‡2
PTBNP|1230752
|
996
|
|
|
‡2
PTBNP|216665
|
996
|
|
|
‡2
PTBNP|108856
|
996
|
|
|
‡2
ISNI|0000000068679217
|
996
|
|
|
‡2
ISNI|0000000070632864
|
996
|
|
|
‡2
PTBNP|170931
|
996
|
|
|
‡2
ISNI|0000000030599473
|
996
|
|
|
‡2
PTBNP|178739
|
996
|
|
|
‡2
RERO|A003752745
|
996
|
|
|
‡2
PTBNP|284386
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|